Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions
Listen to Sandra E. Kurtin, PhD, ANP-C, AOCN, discuss managing drug–drug and drug–food interactions to minimize adverse events in patients receiving BTK inhibitors.
Decera Clinical Education Oncology Podcast · Sandra E. Kurtin PhD ANP-C AOCN
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode,Sandra E. Kurtin, PhD, ANP-C, AOCN, discusses nursing perspectives on avoiding adverse reactions to BTK inhibitor therapy. Topics in this first of 2 podcasts on avoiding AEs include:
- Pharmacokinetics
- Drug metabolism
- Drug–drug interactions
- Drug–food interactions
- The role of CYP enzymes
- Foods to avoid
- Medication review
Presenter:
Sandra E. Kurtin, PhD, ANP-C, AOCN
Director, Advanced Practice and Clinical Integration
The University of Arizona Cancer Center
Assistant Professor, Clinical Medicine
Adjunct Clinical Professor, Nursing
The University of Arizona
Tucson, Arizona
CE/AAPA credit available by visiting the online program:
https://bit.ly/3zMXFOp
Link to full program, including downloadable slidesets:
https://bit.ly/3iwN9Ub
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.